Viracept
Product Images NDC 52959-289

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Viracept (NDC 52959-289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Viracept 01)

Chemical structure diagram of VIRACEPT showing the molecular arrangement of its active ingredient components, including various rings, functional groups, and bonds. The structure features a phenyl group, cyclohexane rings, amide linkages, and a sulfonic acid moiety indicated by CH3SO3H.*

FDA Label Image

Figure 1 (Viracept 02)

A line graph showing the percentage of patients with HIV RNA below 400 copies/mL over a 48-week study period. Three treatment groups are compared: VIRACEPT 750 mg plus ZDV/3TC, VIRACEPT 500 mg plus ZDV/3TC, and placebo plus ZDV/3TC. The graph displays increased viral suppression over time with both VIRACEPT dosage groups compared to placebo.*

FDA Label Image

Figure 2 (Viracept 03)

A line graph showing the mean change in CD4 cell count over 48 study weeks for VIRACEPT 750 mg + ZDV/3TC, VIRACEPT 500 mg + ZDV/3TC, and Placebo + ZDV/3TC groups. The y-axis measures cell count in cells/mm³, and the x-axis shows the study weeks. Data points indicate cell count increases over time with VIRACEPT treatments compared to placebo.*

FDA Label Image

Figure 3 (Viracept 04)

A line graph comparing the percentage of patients with viral load below 400 copies/mL over 48 study weeks. The graph has two data series: BID dosing represented by a blue line with circles and TID dosing represented by a red dashed line with stars, showing changes in viral suppression over time.*

FDA Label Image

Principal Display Panel (250 mg Bottle Label)

VIRACEPT 250mg tablet label showing product NDC 52959-289-30 from H.J. Harkins Company, Inc. The label includes lot number VIR221AU, manufacturing info AGOURON Germany, expiration date 08/10, and comparison to branded Viracept 250mg with NDC 63010-010-30. Pills are described as blue oval tablets, packaged quantity 30 tablets. Additional cautions and barcode are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.